ClinicalTrials.gg
CompletedNCT07904858Updated Oct 29, 2026

Soft Tissue Relaxation in Trumpet Players

An interventional study of Integrated soft tissue relaxation (IASTM + manual release) in Healthy Volunteers and Muscle Tension, sponsored by National Taipei University of Nursing and Health Sciences. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by National Taipei University of Nursing and Health Sciences · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Sep 2025, registered Oct 2026).
Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
20 Years to 50 Years
Sex
All
01

Study summary

This single-group pretest-posttest study examined the immediate effects of a single session of integrated soft tissue relaxation, combining instrument-assisted soft tissue mobilization (IASTM) and manual release techniques, on pulmonary function, resting breathing pattern, trumpet-playing acoustic performance, and perceived exertion in experienced trumpet players.

Read the detailed description

Brass players experience sustained high respiratory and orofacial muscle load. Fifteen healthy adult trumpet players with at least 5 years of playing experience completed baseline assessments, received one 15-20 min session of integrated soft tissue relaxation targeting the perioral, cervicothoracic, intercostal, diaphragmatic, and abdominal regions (IASTM combined with manual release; intensity 3-6 on a 0-10 participant-rated pressure scale), and repeated the same assessments immediately afterwards. Outcomes were forced pulmonary function and resting breathing pattern (CHEST HI-801 spirometer), acoustic features of four standardized playing tasks (automated pYIN-based analysis), and rating of perceived exertion (Borg 6-20).

This study was approved by the Institutional Review Board of Fu Jen Catholic University (C113180) on July 14, 2025, and data collection took place on September 10-17, 2025. The study was registered retrospectively after completion. Maximal inspiratory and expiratory pressures were listed in the approved protocol but could not be measured because the measurement module was unavailable during the data collection period.

02

Conditions studied

  • Healthy Volunteers
  • Muscle Tension

Keywords

  • Manual therapy
  • Instrument-assisted soft tissue mobilization
  • Breathing pattern
  • Pulmonary function
  • Musicians
  • Pitch stability
03

In context

Lead sponsor

National Taipei University of Nursing and Health Sciences is the lead sponsor of 124 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 20-50 years
  • At least 5 years of trumpet-playing experience
  • Current practice or performance within the past 6 months
  • No acute respiratory disease or major chronic illness
  • Willing to provide written

Exclusion criteria

Exclusion Criteria:

  • Recent respiratory tract infection (e.g., common cold, acute asthma exacerbation) or clearly abnormal pulmonary function
  • History of cardiovascular, neuromuscular, or severe neck, shoulder, or thoracic disorders
  • Allergy to massage oil or lubricants
  • Unable or unwilling to complete the study procedures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Integrated soft tissue relaxation

    A single 15-20 min session of IASTM combined with manual release applied in a top-to-bottom sequence to the perioral, cervicothoracic, shoulder girdle, intercostal, diaphragmatic, and abdominal regions.

    Other: Integrated soft tissue relaxation (IASTM + manual release)

Interventions

  • OtherIntegrated soft tissue relaxation (IASTM + manual release)

    Delivered by one trained practitioner according to a written protocol. Pressure was applied during exhalation and eased during inhalation, with intensity titrated to a participant-reported pressure of 3-6 on a 0-10 scale.

06

What researchers measure

Primary outcomes

  1. Forced Vital Capacity (FVC)

    FVC in liters (L), measured with a CHEST HI-801 spirometer.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  2. Resting Minute Ventilation

    Minute ventilation during quiet breathing in liters per minute (L/min), measured with a CHEST HI-801 spirometer.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  3. Forced Expiratory Volume in 1 Second (FEV1)

    FEV1 in liters (L), measured with a CHEST HI-801 spirometer.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  4. Peak Expiratory Flow (PEF)

    PEF in liters per second (L/s), measured with a CHEST HI-801 spirometer.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  5. Maximal Voluntary Ventilation (MVV)

    MVV in liters per minute (L/min), measured with a CHEST HI-801 spirometer.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  6. Resting Tidal Volume

    Tidal volume during quiet breathing in liters (L), measured with a CHEST HI-801 spirometer.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  7. Resting Respiratory Rate

    Respiratory rate during quiet breathing in breaths per minute, measured with a CHEST HI-801 spirometer.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  8. Ventilatory Reserve

    Ventilatory reserve in percent (%), calculated by the CHEST HI-801 spirometer from resting minute ventilation relative to MVV.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

Secondary outcomes

  1. Standard Deviation of Fundamental Frequency During Sustained Note

    Standard deviation of the fundamental frequency in hertz (Hz) during a sustained G4 note, extracted with automated pYIN-based acoustic analysis.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  2. Mean Fundamental Frequency During Sustained Note

    Mean fundamental frequency in hertz (Hz) during a sustained G4 note, extracted with automated pYIN-based acoustic analysis.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  3. Lowest Attainable Pitch

    Lowest fundamental frequency in hertz (Hz) reached during a descending pitch-range task.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  4. Maximal loudness

    Peak sound level in decibels relative to full scale (dBFS) during a G major arpeggio played at maximal controllable loudness.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  5. Highest Attainable Pitch (Hz)

    Highest fundamental frequency in hertz (Hz) reached during an ascending pitch-range task.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  6. Highest Attainable Pitch (MIDI Semitones)

    Highest pitch reached during the ascending pitch-range task, converted to MIDI semitone units.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  7. Rating of perceived exertion

    Rating of perceived exertion on the Borg 6-20 scale (minimum 6, maximum 20; higher scores indicate greater perceived exertion, i.e., a worse outcome), rated immediately after a high-register melody task.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

  8. Sustained-note duration

    Duration in seconds (s) of a sustained G4 note played as long as possible.

    Time frame: Baseline (immediately before) and immediately after the single intervention session (same day)

07

Study locations

1 site
  • National Taipei University of Nursing and Health Sciences, Department of Exercise and Health Science
    Taipei, Taiwan 112303, Taiwan
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because participants consented to the use of their data only for this study, as approved by the ethics committee.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07904858
Responsible party
Wu, Hsiao-Kuan (Assistant Professor, National Taipei University of Nursing and Health Sciences) — Principal investigator
First posted
Oct 29, 2026
Start date
Sep 10, 2025
Primary completion
Sep 17, 2025
Completion
Sep 17, 2025
Last update
Oct 29, 2026

Study contacts

Hsiao-Kuan Wu, PhD
principal investigator · National Taipei University of Nursing and Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion